Oral Microbiota and Oral Status of Adult Patients With Autism Spectrum Disorders (MICAA: MICrobiota Autism Adults)
NCT ID: NCT05910424
Last Updated: 2024-08-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
37 participants
INTERVENTIONAL
2023-11-22
2024-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Systematic Oral Care Program in Post-Mechanically Ventilated, Post-Intensive Care Patients
NCT03886623
Efficacy of A Novel RinSe Device to Reduce Oral Bacteria in Intubated IntEnsive CaRe Patients: a Pilot Study
NCT06193512
The Impact of an Antimicrobial Utilization Program on Antimicrobial Use
NCT00552838
About Oral and Gut Microbiota in Intensive Care Unit : SARS-CoV-2 (COVID-19) Infection Impact.
NCT04913142
Effects of Oral Care in the Neuroscience ICU
NCT00518752
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Investigators will :
* collect saliva, gum fluid and/ or dental plaque to characterise germs
* assess gum health and oral hygiene
* register decays, filled and missing teeth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adults with Autism Spectrum Disorder
* Adults with autism spectrum disorder
* Aged between 18 and 60 years old
* Dental cares and follow-up in Nancy hospital
collection of saliva, gum fluid and/or dental plaque samples
Non-invasive sampling of dental plaque, crevicular fluid and/or saliva, using an examination probe, paper tips and saliva swabs
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
collection of saliva, gum fluid and/or dental plaque samples
Non-invasive sampling of dental plaque, crevicular fluid and/or saliva, using an examination probe, paper tips and saliva swabs
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adult with autism spectrum disorder, men or women aged between 18 and 60.
* Member of a social security scheme or beneficiary of a medical insurance
Exclusion Criteria
* Use of medication or situations that may affect the microbiota (use of antibiotics, probiotics, steroidal or non-steroidal anti-inflammatory drugs in the last 3 months, strict mouth breathing)
* Smoking
* Very lingual position of the teeth hindering clinical assessment of the periodontium
* Patients who have had periodontal treatment for less than 6 months
* Persons covered by articles L. 1121-5 to L. 1121-7 and L1122-2 of the French Public Health Code:
* Pregnant women, women in labour or breast-feeding mothers
* Persons deprived of their liberty by a judicial or administrative decision
* Persons unable to give their consent
* Person under psychiatric care by virtue of articles L. 3212-1 and L. 3213-1 of the Public Health Code
* Minor (not emancipated)
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
BERBE Ludivine
Dentist, University Hospital Assistant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ludivine BERBE
Role: PRINCIPAL_INVESTIGATOR
CHRU Nancy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHRU Brabois
Vandœuvre-lès-Nancy, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-A01024-41
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.